Skip to content

Patient-specific Alloplastic Chin Implant Versus Computer Guided Genioplasty: Soft Tissue Assessment After One Year Follow up

Patient-specific Alloplastic Chin Implant Versus Computer Guided Genioplasty: Soft Tissue Assessment After One Year Follow up

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04817930
Enrollment
20
Registered
2021-03-26
Start date
2019-01-01
Completion date
2021-01-01
Last updated
2021-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chin Microgenia

Keywords

Chin microgenia, Orthognathic

Brief summary

Two groups with retruded chin skeletal deformity. one treated with patient specific alloplastic implant and the other was treated with computer guided advancement genioplasty. soft tissue assessment was executed after one year

Interventions

DEVICEPolyetheretherketone patient specific implant

a customized peek patient specific implant is place to augment the chin

advancement genioplasty using patient specific cutting and positioning surgical stents

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients whose clinical features revealed possible correction of their facial deformity using chin surgery only * No prior surgery involving the chin

Exclusion criteria

* Patients whose clinical features revealed possible correction of their facial deformity using mandibular surgeries. * Patients with systemic diseases that carried high risk for general anesthesia.

Design outcomes

Primary

MeasureTime frameDescription
soft tissue effectafter one yearThe impact of the interventions on the soft tissue gain after one year

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026